Page last updated: 2024-09-04

moxifloxacin and rivaroxaban

moxifloxacin has been researched along with rivaroxaban in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (rivaroxaban)	Trials (rivaroxaban)	Recent Studies (post-2010) (rivaroxaban)
3,157	552	1,690	4,741	569	4,357

Protein Interaction Comparison

Protein	Taxonomy	moxifloxacin (IC50)	rivaroxaban (IC50)
Coagulation factor X	Homo sapiens (human)		0.0038

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becka, M; Kubitza, D; Mueck, W	1

Trials

1 trial(s) available for moxifloxacin and rivaroxaban

Article	Year
Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation. Drug safety, 2008, Volume: 31, Issue:1 Topics: Administration, Oral; Aged; Algorithms; Antithrombin III; Aza Compounds; Blood Coagulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Moxifloxacin; Prospective Studies; Quinolines; Rivaroxaban; Sex Factors; Thiophenes; Time Factors	2008

Article

Year

Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.

Drug safety, 2008, Volume: 31, Issue:1

Topics: Administration, Oral; Aged; Algorithms; Antithrombin III; Aza Compounds; Blood Coagulation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fluoroquinolones; Heart Rate; Humans; Male; Metabolic Clearance Rate; Middle Aged; Morpholines; Moxifloxacin; Prospective Studies; Quinolines; Rivaroxaban; Sex Factors; Thiophenes; Time Factors

2008